Tag: ADOCIA
Adocia: the title climbs, positive results of a study
(CercleFinance.com) – The title Adocia wins more than 10% Thursday morning on the Paris Stock Exchange following the announcement by the biopharmaceutical company of favorable results in the treatment of…
ADOCIA announces its participation in investor conferences in January 2023 – 2022-12-21 at 18:00
6:00 p.m. CET – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…
ADOCIA: Information relating to the number of shares and voting rights as of November 30, 2022 – 12/15/2022 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of November 30, 2022 6 p.m. CET – In accordance with the provisions of Article L.233-8 II of…
ADOCIA: Information relating to the number of shares and voting rights as of October 31, 2022 – 11/16/2022 at 6:00 p.m.
ADOCIA: Information relating to the number of shares and voting rights as of October 31, 2022 6 p.m. CET – In accordance with the provisions of Article L.233-8 II of…
Adocia: increase in its turnover in the third quarter of 2022 – 25/10/2022 at 18:13
(AOF) – Adocia, a biopharmaceutical company, has published its cash position and its turnover for the third quarter and provided an assessment of its activities. Its total revenue at the…
Adocia: CDC holds less than 15% of DDVs
(CercleFinance.com) – The Caisse des dépôts et consignations (CDC) declared that it crossed downwards on October 13, 2022, indirectly, through the intermediary of the company Bpifrance Investissement, which acts on…
ADOCIA: Information relating to the number of shares and voting rights as of September 30, 2022 – 10/13/2022 at 6:00 p.m.
6 p.m. CEST – In accordance with the provisions of Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés…
Adocia soars after positive new data for M1Pram
By Jean-Baptiste Andre Published on 06/10/2022 at 14:21 (Boursier.com) — Adocia…
Adocia: exceptional results for M1Pra in obese people with type 1 diabetes – 06/10/2022 at 14:00
(Photo credits: Adobe Stock – ) (AOF) – According to its study results, the biotechnology company Adocia announces an exceptional weight loss of 5.5 kg with M1Pram in obese people…
ADOCIA: Upcoming investor meetings – 2022/10/03 at 6:00 p.m.
6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…
Adocia publishes solid half-year results – 09/19/2022 at 18:26
(AOF) – Adocia, a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, has announced its financial…
Adocia will publish its 2022 half-year results on September 19 and will hold a webinar on September 20 – 09/15/2022 at 6:00 p.m.
6 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…